Welcome to our dedicated page for F5 SEC filings (Ticker: FFIV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
F5, Inc. filings document regulatory disclosures for an application delivery and security company with products and services used across enterprise, service provider, and government markets. Recent Form 8-K reports furnish quarterly results, financial-condition updates, Regulation FD materials, board appointments, director compensation arrangements, and material cybersecurity incident disclosures involving company systems and product-development environments.
The company’s proxy materials cover director elections, shareholder voting results, executive compensation, equity incentive plans, non-employee director compensation, auditor ratification, and governance practices. These filings also describe common-stock authorization for incentive awards, committee assignments, exhibits to earnings releases, and other public-company reporting matters.
F5, Inc. announced that it has entered into an acquisition arrangement with Calypso AI Corp, a Delaware corporation. Under this agreement, and subject to its stated terms and conditions, Calypso AI will become a direct, wholly owned subsidiary of F5.
The announcement was made through a press release furnished as Exhibit 99.1 under Item 7.01 of a current report. The press release and related information are being furnished, not filed, which means they are not automatically subject to certain Exchange Act liability provisions or incorporation by reference into other documents unless specifically stated.
F5, Inc. (FFIV) Form 4 summary — The reporting person, Schramm Lyra Amber, identified as Chief People Officer, reported a sale of 2,701 shares of F5 common stock on 09/08/2025 at a price of $316.57 per share. The filing states the transaction was executed pursuant to a Rule 10b5-1 trading plan dated 06/09/2025. Following the reported disposition the filing shows 0 shares beneficially owned. The Form 4 was signed by Angelique M. Okeke by power of attorney on 09/09/2025. This disclosure records an officer-initiated sale under a pre-established plan; no additional financial results, forward guidance, or other transactions are included in this filing.
Form 144 filed for F5, Inc. (FFIV) shows a proposed sale of 2,701 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $855,055.57. The filing lists three tranches of restricted stock acquired from the issuer on 02/01/2025 (200 shares), 05/01/2025 (2,291 shares), and 08/01/2025 (210 shares), all paid on their acquisition dates. No securities were reported sold in the prior three months. The filer certifies they are not aware of undisclosed material adverse information. The notice documents the intent to sell shares by an individual for whose account the securities were issued and identifies the executing broker and approximate sale date of 09/08/2025.
Locoh-Donou Francois, President, CEO & Director of F5, Inc. (FFIV), reported a sale of 1,300 shares of common stock on 09/02/2025 at a price of $309.61 per share. After the sale, he beneficially owned 108,853 shares directly and 42,000 shares indirectly through a family trust. The Form 4 indicates the sale was executed pursuant to a Rule 10b5-1 trading plan dated 11/13/2024. The filing was signed by an authorized representative by power of attorney on 09/04/2025.
Form 144 notice indicates proposed sale of 1,300 common shares by an officer/person for whose account the securities are to be sold, to be executed through Morgan Stanley Smith Barney LLC on 09/02/2025 with an aggregate market value of $402,493.00. The filing shows the 1,300 shares were acquired as restricted stock on 02/01/2021 (589 shares) and 11/01/2022 (711 shares). The issuer’s outstanding shares are listed as 57,447,170. The filing also discloses two prior common-stock sales by the same person: 1,300 shares on 08/01/2025 for $400,582.00 and 1,300 shares on 07/01/2025 for $382,616.00. The signer represents they are not aware of undisclosed material adverse information and includes the standard criminal-misstatement warning.
Chad Michael Whalen, EVP Worldwide Sales of F5, Inc. (FFIV), reported multiple open-market sales executed under a Rule 10b5-1 trading plan dated April 30, 2025. The filing shows four sales on 08/11/2025 totaling 5,297 shares, with weighted-average sale prices running from $320.24 to $323.07 per share.
Those entries in Table I show the reporting person’s direct beneficial ownership declining across the transactions to a reported holding of 23,591 shares following the sales. The filing notes the transactions were made pursuant to the pre-established 10b5-1 plan and provides weighted-price ranges for transparency.
F5, Inc. filed a Form 144 notice indicating a proposed sale of 5,297 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 08/11/2025. The filing lists an aggregate market value of $1,706,874.03 and shows 57,447,170 shares outstanding, indicating the proposed sale is a small portion of the company's total shares.
The shares were acquired as restricted stock from the issuer on 08/01/2018 and payment is recorded as on that date. The filer reports no securities sold in the past three months and makes the standard representation that they do not possess undisclosed material information; the filing references Rule 10b5-1 language but does not provide a plan adoption date.
FFIV Q3 FY25 (quarter ended 30 Jun 2025) snapshot:
- Revenue $780.4 m, +12% YoY; product $388.8 m (+26%), services $391.5 m (+1%).
- Gross margin 81.0% (+60 bp); operating margin 25.2% (+180 bp).
- Net income $189.9 m (+32%); diluted EPS $3.25 (+33%).
- Nine-month operating cash flow $741.6 m; cash & investments $1.43 bn (up $359 m since 9/24); no debt after $350 m revolver expired 1/31/25.
- Deferred revenue grew to $1.96 bn (+9% vs 9/24); RPO $2.0 bn with 61% due within 12 months.
- Share buy-backs: 0.49 m shares for $125 m; $1.05 bn capacity remains.
- Systems revenue rebounded (+39%) and now 46.5% of product mix; software +16%.
- OpEx +10% YoY (R&D +10%, G&A +19%); FY25 YTD restructuring charges $11.3 m.
- Effective tax rate fell to 10.8% (vs 16.0%); diluted share count -1.1% YoY.
Balance sheet strong: assets $6.11 bn, long-term liabilities $1.09 bn, equity $3.47 bn. Two immaterial acquisitions added $12 m goodwill; no impairment or credit issues disclosed.